Results 151 to 160 of about 14,352 (184)
Some of the next articles are maybe not open access.

Polyglutamine Diseases and Molecular Chaperones

IUBMB Life, 2003
AbstractThe polyglutamine diseases, a group of diseases currently thought to consist of nine inherited neurodegenerative diseases, are caused by the expansion of unstable CAG trinucleotide repeats that code for polyglutamine tracts in the responsible genes.
Yoko, Kimura, Akira, Kakizuka
openaire   +2 more sources

Polyglutamine protein aggregates are dynamic

Nature Cell Biology, 2002
Protein aggregation and the formation of inclusion bodies are hallmarks of the cytopathology of neurodegenerative diseases, including Huntington's disease, Amyotropic lateral sclerosis, Parkinson's disease and Alzheimer's disease. The cellular toxicity associated with protein aggregates has been suggested to result from the sequestration of essential ...
Soojin, Kim   +4 more
openaire   +2 more sources

Therapeutic opportunities in polyglutamine disease

Nature Medicine, 2001
Polyglutamine diseases comprise a class of familial neurodegenerative disorders caused by expression of proteins containing expanded polyglutamine tracts. Great progress has been made in elucidating the molecular mechanisms contributing to polyglutamine pathology, and in identifying potential drug targets.
R E, Hughes, J M, Olson
openaire   +2 more sources

Polyglutamine and Neurodegeneration: Structural Aspects

Protein & Peptide Letters, 2004
Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders caused by proteins with expanded polyQ regions. Although the pathological mechanisms of these diseases have not yet been elucidated, the processes of protein misfolding and aggregation seem to be a direct cause of neurodegeneration.
openaire   +2 more sources

Polyglutamine expansion neurodegenerative disease

Brain Research Bulletin, 2001
Kennedy's disease was the first of eight neurodegenerative disorders found to be caused by expanded polyglutamine repeats. Each of these disorders is likely caused by a toxic gain of function in the disease gene product, often associated with inclusions of mutant protein in susceptible neurons.
openaire   +2 more sources

Gene Therapies for Polyglutamine Diseases

2018
Polyglutamine diseases are hereditary degenerative disorders of the nervous system that have remained, to this date, untreatable. Promisingly, investigation into their molecular etiology and the development of increasingly perfected tools have contributed to the design of novel strategies with therapeutic potential.
Carlos A, Matos   +8 more
openaire   +2 more sources

Polyglutamine diseases

Trends in Genetics, 1999
Majid Hafezparast, Elizabeth Fisher
openaire   +1 more source

Polyglutamine Diseases

2007
Meyer J. Friedman   +2 more
openaire   +2 more sources

Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?

Journal of Molecular Cell Biology, 2010
Osamu Onodera, Onodera Osamu
exaly  

Home - About - Disclaimer - Privacy